postpartum
发表于 2025-3-21 19:55:08
书目名称Wicked Women of Tudor England影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK1028207<br><br> <br><br>书目名称Wicked Women of Tudor England影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK1028207<br><br> <br><br>书目名称Wicked Women of Tudor England网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK1028207<br><br> <br><br>书目名称Wicked Women of Tudor England网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK1028207<br><br> <br><br>书目名称Wicked Women of Tudor England被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK1028207<br><br> <br><br>书目名称Wicked Women of Tudor England被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK1028207<br><br> <br><br>书目名称Wicked Women of Tudor England年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK1028207<br><br> <br><br>书目名称Wicked Women of Tudor England年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK1028207<br><br> <br><br>书目名称Wicked Women of Tudor England读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK1028207<br><br> <br><br>书目名称Wicked Women of Tudor England读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK1028207<br><br> <br><br>
DEMUR
发表于 2025-3-21 20:26:46
http://reply.papertrans.cn/103/10283/1028207/1028207_2.png
翻动
发表于 2025-3-22 01:53:08
Wicked Women of Tudor England978-0-230-39193-2Series ISSN 2730-938X Series E-ISSN 2730-9398
evaculate
发表于 2025-3-22 05:12:08
Queenship and Powerhttp://image.papertrans.cn/w/image/1028207.jpg
Cantankerous
发表于 2025-3-22 11:05:18
http://reply.papertrans.cn/103/10283/1028207/1028207_5.png
cornucopia
发表于 2025-3-22 13:04:21
https://doi.org/10.1057/9780230391932England; society; women
affect
发表于 2025-3-22 19:34:10
2730-938XBoleyn, Katherine Howard, Anne Seymour, Lettice Dudley, and Jane and Alice More. Warnicke rescues these women from historical misrepresentations and helps us to rediscover the complex world of Tudor society.978-1-137-03237-9978-0-230-39193-2Series ISSN 2730-938X Series E-ISSN 2730-9398
遗传学
发表于 2025-3-22 21:13:26
http://reply.papertrans.cn/103/10283/1028207/1028207_8.png
Expand
发表于 2025-3-23 04:52:49
J. Michael Fingerry seems to be the best treatment option available. The addition of adjuvant checkpoint inhibition in the presence of residual disease seems to be the best augment for this approach. However, significant regional differences exist in this setting as well with docetaxel-based therapy emerging as a vi
积云
发表于 2025-3-23 08:00:48
http://reply.papertrans.cn/103/10283/1028207/1028207_10.png